STOCK TITAN

Innoviva (NASDAQ: INVA) director granted RSUs and 10,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Innoviva, Inc. director Derek A. Small received equity awards tied to his board service. He acquired 9,786 shares of common stock through restricted stock units at no cost and now holds 45,035 shares directly. He was also granted non-statutory stock options for 10,000 shares of common stock at an exercise price of $22.99 per share, expiring in 2036. All RSUs and options vest 100% at the earlier of the next annual stockholder meeting or the one-year anniversary of grant, with accelerated vesting upon death, disability, or certain change in control events.

Positive

  • None.

Negative

  • None.
Insider Small Derek A
Role null
Type Security Shares Price Value
Grant/Award Non-statutory Stock Option 10,000 $0.00 --
Grant/Award Common Stock 9,786 $0.00 --
Holdings After Transaction: Non-statutory Stock Option — 10,000 shares (Direct, null); Common Stock — 45,035 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant 9,786 shares Restricted stock units granted on May 4, 2026
Shares held after grant 45,035 shares Common stock directly owned after transactions
Option grant size 10,000 options Non-statutory stock options granted May 4, 2026
Option exercise price $22.99 per share Exercise price for 10,000 non-statutory stock options
Option expiration May 3, 2036 Expiration date for non-statutory stock options
restricted stock units financial
"The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Non-statutory Stock Option financial
"security_title": "Non-statutory Stock Option""
A non-statutory stock option is a company-granted right that lets a person buy shares later at a set price but does not receive special tax-favored treatment under tax law. It matters to investors because when the option is used the holder usually pays ordinary income tax on the gain and the company records compensation cost and issues new shares, which can reduce existing owners’ percentage ownership—think of it like a coupon to buy stock that creates a taxable event and some dilution.
Outside Director financial
"subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date"
change in control financial
"in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
2026 Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Small Derek A

(Last)(First)(Middle)
1350 OLD BAYSHORE HIGHWAY, SUITE 400

(Street)
BURLINGAME CALIFORNIA 94010

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Innoviva, Inc. [ INVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/04/2026A9,786(1)A$045,035D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-statutory Stock Option$22.9905/04/2026A10,00005/04/2027(1)05/03/2036Common Stock10,000$010,000D
Explanation of Responses:
1. The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon the conclusion of the Issuer's 2026 annual meeting of stockholders. 100% of the RSUs and Options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.
/s/ Derek Small05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Innoviva (INVA) report for Derek A. Small?

Innoviva reported that director Derek A. Small received 9,786 restricted stock units and 10,000 non-statutory stock options as compensation. These grants increased his direct holdings and align his interests with shareholders through equity-based incentives tied to continued board service.

How many Innoviva (INVA) shares does Derek A. Small hold after this Form 4?

After the equity awards, Derek A. Small directly holds 45,035 shares of Innoviva common stock. This figure reflects the updated ownership position reported, providing context on his stake size as a board member following the 9,786-share RSU grant.

What are the terms of Derek A. Small’s Innoviva (INVA) stock options?

Small’s non-statutory stock options cover 10,000 shares of Innoviva common stock at a $22.99 exercise price. The options were granted in 2026, fully vest on the earlier of the next annual stockholder meeting or one year after grant, and expire in 2036 if not exercised.

When do Derek A. Small’s Innoviva (INVA) RSUs and options vest?

All RSUs and options vest 100% at the sooner of the next annual stockholder meeting or the one-year anniversary of grant. Vesting is conditioned on his continuous service as an Outside Director, with accelerated vesting upon death, disability, or a qualifying change in control.

Were Derek A. Small’s Innoviva (INVA) equity grants open-market purchases?

No, the 9,786 RSUs and 10,000 options were compensation awards, not open-market purchases. They were granted at a reported price of $0.00 per unit, with options exercisable later at $22.99 per share, reflecting standard board equity compensation structure.

What triggers accelerated vesting of Innoviva (INVA) awards for Derek A. Small?

Accelerated vesting occurs upon Derek A. Small’s death, disability, or a defined change in control, provided his service has not terminated earlier. Under these events, his unvested RSUs and options become fully vested, according to Innoviva’s 2026 Equity Incentive Plan terms.